Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Entegris
ENTG
$22.8B
| $115K | ﹤0.01% |
+8,922
| New | +$108K |
|
4152
PUT
Fomento Económico Mexicano
FMX
$40.7B
| $115K | ﹤0.01% |
+1,200
| New | +$110K |
|
4153
Puma Biotechnology
PBYI
$448M
| $115K | ﹤0.01% |
3,961
+3,245
| +453% | +$147K |
|
4154
Sonida Senior Living
SNDA
$2.02B
| $115K | ﹤0.01% |
427
-3,025
| -88% | -$788K |
|
|
ACHN
4155
DELISTED
Achillion Pharmaceuticals
ACHN
| $115K | ﹤0.01% |
16,440
-60,976
| -79% | -$447K |
|
4156
ProShares Ultra Dow30
DDM
$552M
| $114K | ﹤0.01% |
+10,332
| New | +$101K |
|
|
HDV
4157
iShares Core High Dividend ETF
HDV
$15B
| $114K | ﹤0.01% |
7,300
| – | – |
|
4158
PUT
Prologis
PLD
$132B
| $114K | ﹤0.01% |
2,600
+1,400
| +117% | +$56.2K |
|
4159
Take-Two Interactive
TTWO
$47.1B
| $114K | ﹤0.01% |
3,092
+2,930
| +1,809% | +$101K |
|
|
ASNA
4160
PUT
DELISTED
Ascena Retail Group, Inc.
ASNA
| $114K | ﹤0.01% |
518
-2,097
| -80% | -$370K |
|
|
MSLI
4161
DELISTED
Merus Labs International Inc.
MSLI
| $114K | ﹤0.01% |
+113,700
| New | +$158K |
|
|
CSH
4162
PUT
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $114K | ﹤0.01% |
3,000
| – | – |
|
|
CY
4163
PUT
DELISTED
Cypress Semiconductor
CY
| $114K | ﹤0.01% |
14,300
+9,900
| +225% | +$79.9K |
|
4164
CALL
Aptiv
APTV
$10.4B
| $113K | ﹤0.01% |
1,500
+500
| +50% | +$34.2K |
|
4165
PUT
Boston Scientific
BSX
$73.1B
| $113K | ﹤0.01% |
6,300
-26,000
| -80% | -$457K |
|
|
SAVE
4166
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $113K | ﹤0.01% |
2,400
-500
| -17% | -$22.4K |
|
|
HTWR
4167
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $113K | ﹤0.01% |
3,656
-6,994
| -66% | -$237K |
|
4168
AeroVironment
AVAV
$9.45B
| $112K | ﹤0.01% |
4,009
-2,040
| -34% | -$53.2K |
|
4169
PUT
Cedar Fair
FUN
$1.61B
| $112K | ﹤0.01% |
+1,900
| New | +$105K |
|
4170
CALL
ING
ING
$102B
| $112K | ﹤0.01% |
10,200
-6,400
| -39% | -$76.8K |
|
4171
Rockwell Medical
RMTI
$27M
| $112K | ﹤0.01% |
+146
| New | +$115K |
|
4172
TTM Technologies
TTMI
$13.6B
| $112K | ﹤0.01% |
18,587
+3,118
| +20% | +$19.2K |
|
4173
United Bankshares
UBSI
$6.6B
| $112K | ﹤0.01% |
3,119
-109
| -3% | -$3.83K |
|
4174
ProShares Ultra Gold
UGL
$807M
| $112K | ﹤0.01% |
11,500
+10,764
| +1,463% | +$99.6K |
|
|
HCR
4175
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $112K | ﹤0.01% |
28,037
-8,288
| -23% | -$40.8K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.